Par Drugs (India) Price History
PAR Stock | 288.35 4.15 1.42% |
Below is the normalized historical share price chart for Par Drugs And extending back to May 30, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Par Drugs stands at 288.35, as last reported on the 27th of November, with the highest price reaching 294.85 and the lowest price hitting 285.30 during the day.
If you're considering investing in Par Stock, it is important to understand the factors that can impact its price. Par Drugs appears to be very steady, given 3 months investment horizon. Par Drugs And maintains Sharpe Ratio (i.e., Efficiency) of 0.0647, which implies the firm had a 0.0647% return per unit of risk over the last 3 months. We have found thirty technical indicators for Par Drugs And, which you can use to evaluate the volatility of the company. Please evaluate Par Drugs' Risk Adjusted Performance of 0.0796, semi deviation of 2.06, and Coefficient Of Variation of 1069.03 to confirm if our risk estimates are consistent with your expectations.
As of November 27, 2024, Total Stockholder Equity is expected to decline to about 483.9 M. In addition to that, Common Stock Shares Outstanding is expected to decline to about 11.2 M. Par Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
200 Day MA 242.7506 | 50 Day MA 260.6474 | Beta 0.153 |
Par |
Sharpe Ratio = 0.0647
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | PAR | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
4.0 actual daily | 35 65% of assets are more volatile |
Expected Return
0.26 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
0.06 actual daily | 5 95% of assets perform better |
Based on monthly moving average Par Drugs is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Par Drugs by adding it to a well-diversified portfolio.
Price Book 3.6668 | Book Value 78.685 | Enterprise Value 3.4 B | Enterprise Value Ebitda 11.9454 | Price Sales 3.4024 |
Par Drugs Stock Price History Chart
There are several ways to analyze Par Stock price data. The simplest method is using a basic Par candlestick price chart, which shows Par Drugs price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | November 4, 2024 | 305.5 |
Lowest Price | October 7, 2024 | 221.1 |
Par Drugs November 27, 2024 Stock Price Synopsis
Various analyses of Par Drugs' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Par Stock. It can be used to describe the percentage change in the price of Par Drugs from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Par Stock.Par Drugs Price Action Indicator | (3.80) | |
Par Drugs Price Daily Balance Of Power | (0.43) | |
Par Drugs Price Rate Of Daily Change | 0.99 |
Par Drugs November 27, 2024 Stock Price Analysis
Par Stock Price History Data
The price series of Par Drugs for the period between Thu, Aug 29, 2024 and Wed, Nov 27, 2024 has a statistical range of 84.4 with a coefficient of variation of 10.1. The price distribution for the period has arithmetic mean of 256.43. The median price for the last 90 days is 244.69. The company completed stock split (2:1) on 27th of April 2021. Par Drugs And had dividends distributed to its stock-holders on 2021-11-22.Open | High | Low | Close | Volume | ||
11/27/2024 | 292.50 | 294.85 | 285.30 | 288.35 | ||
11/26/2024 | 292.50 | 294.85 | 285.30 | 288.35 | 173,146 | |
11/25/2024 | 299.00 | 304.65 | 289.00 | 292.50 | 211,545 | |
11/22/2024 | 283.90 | 307.00 | 281.50 | 294.05 | 534,126 | |
11/21/2024 | 283.50 | 290.65 | 280.00 | 281.40 | 74,976 | |
11/20/2024 | 289.35 | 289.35 | 289.35 | 289.35 | 1.00 | |
11/19/2024 | 271.60 | 297.90 | 268.95 | 289.35 | 864,073 | |
11/18/2024 | 272.00 | 275.20 | 255.15 | 267.60 | 123,761 | |
11/14/2024 | 270.10 | 278.00 | 270.10 | 271.10 | 58,016 | |
11/13/2024 | 268.15 | 277.75 | 268.05 | 269.00 | 66,012 | |
11/12/2024 | 293.70 | 293.70 | 271.05 | 273.55 | 90,054 | |
11/11/2024 | 292.10 | 299.10 | 282.60 | 285.50 | 79,187 | |
11/08/2024 | 310.00 | 311.05 | 290.00 | 291.95 | 109,693 | |
11/07/2024 | 299.20 | 302.40 | 290.05 | 299.20 | 111,672 | |
11/06/2024 | 305.90 | 305.90 | 287.50 | 299.00 | 119,659 | |
11/05/2024 | 310.00 | 315.25 | 301.00 | 302.60 | 90,830 | |
11/04/2024 | 318.00 | 320.00 | 302.00 | 305.50 | 152,497 | |
11/01/2024 | 294.70 | 294.70 | 294.70 | 294.70 | 298,111 | |
10/31/2024 | 295.00 | 298.25 | 288.00 | 294.70 | 52,392 | |
10/30/2024 | 297.00 | 300.80 | 285.00 | 293.21 | 70,778 | |
10/29/2024 | 310.00 | 310.00 | 293.36 | 295.61 | 189,661 | |
10/28/2024 | 275.00 | 310.00 | 275.00 | 299.55 | 373,595 | |
10/25/2024 | 280.00 | 286.00 | 247.21 | 274.45 | 235,782 | |
10/24/2024 | 305.00 | 312.00 | 281.00 | 286.01 | 724,521 | |
10/23/2024 | 266.56 | 266.56 | 266.56 | 266.56 | 100,741 | |
10/22/2024 | 234.60 | 240.92 | 218.00 | 222.14 | 17,552 | |
10/21/2024 | 240.00 | 255.00 | 232.00 | 233.33 | 109,125 | |
10/18/2024 | 237.30 | 237.98 | 230.50 | 231.81 | 10,725 | |
10/17/2024 | 245.70 | 246.38 | 233.01 | 239.43 | 18,024 | |
10/16/2024 | 245.00 | 245.80 | 240.00 | 244.46 | 17,072 | |
10/15/2024 | 239.90 | 248.00 | 236.00 | 244.69 | 115,396 | |
10/14/2024 | 235.20 | 241.97 | 235.10 | 239.38 | 20,531 | |
10/11/2024 | 224.00 | 247.69 | 223.01 | 234.99 | 75,835 | |
10/10/2024 | 225.60 | 225.90 | 220.35 | 221.65 | 26,528 | |
10/09/2024 | 226.95 | 228.85 | 218.80 | 221.10 | 37,304 | |
10/08/2024 | 227.10 | 227.10 | 222.10 | 223.64 | 23,368 | |
10/07/2024 | 234.05 | 241.00 | 218.02 | 221.10 | 167,457 | |
10/04/2024 | 234.00 | 239.52 | 229.48 | 235.60 | 129,932 | |
10/03/2024 | 230.00 | 236.09 | 226.51 | 230.40 | 16,981 | |
10/01/2024 | 232.96 | 237.78 | 230.20 | 232.06 | 10,059 | |
09/30/2024 | 237.65 | 238.45 | 227.20 | 231.75 | 23,018 | |
09/27/2024 | 242.20 | 244.60 | 236.55 | 237.55 | 9,399 | |
09/26/2024 | 238.55 | 243.00 | 235.60 | 242.15 | 19,588 | |
09/25/2024 | 242.00 | 243.75 | 236.10 | 238.65 | 11,412 | |
09/24/2024 | 241.20 | 243.40 | 235.25 | 236.30 | 31,487 | |
09/23/2024 | 243.70 | 248.85 | 235.50 | 243.40 | 38,910 | |
09/20/2024 | 237.55 | 245.10 | 237.55 | 243.70 | 28,925 | |
09/19/2024 | 244.00 | 244.00 | 233.00 | 234.05 | 30,500 | |
09/18/2024 | 242.10 | 247.95 | 238.00 | 238.85 | 29,679 | |
09/17/2024 | 246.00 | 258.90 | 239.90 | 242.10 | 55,752 | |
09/16/2024 | 257.15 | 268.00 | 241.30 | 246.25 | 47,529 | |
09/13/2024 | 264.60 | 264.60 | 252.35 | 257.15 | 59,683 | |
09/12/2024 | 238.50 | 271.95 | 236.55 | 259.85 | 288,535 | |
09/11/2024 | 235.90 | 245.50 | 235.10 | 237.30 | 14,408 | |
09/10/2024 | 235.30 | 240.00 | 232.00 | 237.45 | 13,737 | |
09/09/2024 | 240.20 | 241.95 | 235.00 | 237.05 | 15,174 | |
09/06/2024 | 240.60 | 253.00 | 235.55 | 237.20 | 38,293 | |
09/05/2024 | 241.50 | 245.65 | 237.15 | 239.30 | 10,221 | |
09/04/2024 | 242.80 | 245.95 | 237.25 | 240.25 | 11,656 | |
09/03/2024 | 254.70 | 254.70 | 245.00 | 246.50 | 9,185 | |
09/02/2024 | 259.00 | 260.00 | 247.00 | 249.20 | 14,800 |
About Par Drugs Stock history
Par Drugs investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Par is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Par Drugs And will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Par Drugs stock prices may prove useful in developing a viable investing in Par Drugs
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 14.2 M | 11.2 M | |
Net Income Applicable To Common Shares | 106 M | 65.2 M |
Par Drugs Quarterly Net Working Capital |
|
Par Drugs Stock Technical Analysis
Par Drugs technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Sync Your Broker Now
Sync Your BrokerSync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
All Next | Launch Module |
Par Drugs Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Par Drugs' price direction in advance. Along with the technical and fundamental analysis of Par Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Par to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0796 | |||
Jensen Alpha | 0.3675 | |||
Total Risk Alpha | (0.27) | |||
Sortino Ratio | 0.104 | |||
Treynor Ratio | (15.86) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Par Stock analysis
When running Par Drugs' price analysis, check to measure Par Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Par Drugs is operating at the current time. Most of Par Drugs' value examination focuses on studying past and present price action to predict the probability of Par Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Par Drugs' price. Additionally, you may evaluate how the addition of Par Drugs to your portfolios can decrease your overall portfolio volatility.
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Transaction History View history of all your transactions and understand their impact on performance | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |